OptiBiotix Health Plc (FRA:OB3)

Revenue by Product

Financials in millions GBX. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
Microbial Strains, Compounds and Formulations	644.00K

Revenue by Geography

Financials in millions GBX. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
United Kingdom	221.00K
United Kingdom Growth	62.50%
United States	202.00K
United States Growth	102.00%
Rest of World	146.00K
Rest of World Growth	-8.75%
China	75.00K